

CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 50 TABLETS x 20 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 10–40 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED AT RECEPTOR LEVEL
MANUFACTURER: AXIOLABS
Tamoxiplex 20 by Axiolabs delivers 20 mg of pharmaceutical-grade Tamoxifen Citrate per tablet — a trusted SERM used for managing estrogen-related side effects and supporting natural testosterone recovery post-cycle.
Tamoxifen is a selective estrogen receptor modulator (SERM) that works by blocking estrogen receptors in targeted tissues, especially in the breast. While it does not reduce estrogen levels in the blood, it prevents estrogen from binding where it can cause gynecomastia and other side effects.
During PCT, Tamoxiplex is typically used at 40 mg/day for the first week, followed by 20 mg/day for 2–3 more weeks. It may also be used during cycle at 10–20 mg/day for mild gynecomastia symptoms or estrogenic flare-ups.
Tamoxiplex is commonly stacked with:
Use Tamoxiplex as part of your PCT following cycles with suppressive compounds such as:
Order original Tamoxiplex 20 mg by Axiolabs with fast and discreet U.S. delivery. Explore our full Axiolabs steroid catalog for PCT and on-cycle protection solutions.
Reference: PubMed study on tamoxifen and hormonal recovery.
Yes, it can be used on cycle to combat early signs of gynecomastia by blocking estrogen at the receptor level.
No. Arimiplex (Anastrozole) lowers estrogen levels, while Tamoxiplex blocks estrogen at the receptor. They are often used together for full coverage.
Typical duration is 3–4 weeks. Start with 40 mg/day in week 1, then reduce to 20 mg/day for weeks 2–4.
Please log in to write TAMOXIPLEX 20 MG review.
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 50 TABLETS x 50 MG
ACTIVE HALF-LIFE: 5-7 DAYS
DOSAGE: MEN 25–100 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS x 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED RISK
HEPATOTOXICITY: NO
AROMATIZATION: PERMANENTLY BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: 0.25–1.25 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED (POTENT)
MANUFACTURER: AXIOLABS